Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Total Non-Current Liabilities (2016 - 2025)

Ironwood Pharmaceuticals' Total Non-Current Liabilities history spans 14 years, with the latest figure at $637.1 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities changed 0.31% year-over-year to $637.1 million; the TTM value through Dec 2025 reached $637.1 million, changed 0.31%, while the annual FY2025 figure was $637.1 million, 0.31% changed from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $637.1 million at Ironwood Pharmaceuticals, roughly flat from $638.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.1 billion in Q4 2023 and bottomed at $436.3 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $631.9 million (2024), against an average of $672.7 million.
  • The largest annual shift saw Total Non-Current Liabilities surged 388.46% in 2023 before it tumbled 70.34% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $517.5 million in 2021, then dropped by 15.29% to $438.4 million in 2022, then soared by 388.46% to $2.1 billion in 2023, then crashed by 70.34% to $635.1 million in 2024, then grew by 0.31% to $637.1 million in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Total Non-Current Liabilities are $637.1 million (Q4 2025), $638.0 million (Q3 2025), and $628.6 million (Q2 2025).